Mesoporous Polydopamine Loaded Pirfenidone Target to Fibroblast Activation Protein for Pulmonary Fibrosis Therapy

Mesoporous Polydopamine Loaded Pirfenidone Target to Fibroblast Activation Protein for Pulmonary Fibrosis Therapy

Recently, fibroblast activation protein (FAP), an overexpressed transmembrane protein of activated fibroblast in pulmonary fibrosis, has been considered as the new target for diagnosing and treating pulmonary fibrosis. In this work, mesoporous polydopamine (MPDA), which is facile prepared and easily...

Full description

Bibliographic Details
Main Authors: Qi Fang, Shaoyu Liu, Jiangyu Cui, Ruiyue Zhao, Qian Han, Peng Hou, Youcai Li, Jie Lv, Xiaoyao Zhang, Qun Luo, Xinlu Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
mesoporous polydopamine
fibroblast activation protein
fibroblast activation protein inhibitor
pulmonary fibrosis
antifibrosis therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fbioe.2022.920766/full

Internet

https://www.frontiersin.org/articles/10.3389/fbioe.2022.920766/full

Similar Items